Grifols is a global healthcare company that specializes in the production of plasma-derived medicines. The company was founded in 1940 in Barcelona, Spain, and has since grown to become a leading producer of plasma-based products. Grifols operates in more than 100 countries and has a workforce of over 24,000 employees. The company's products are used to treat a variety of medical conditions, including immune deficiencies, bleeding disorders, and neurological conditions. Grifols is committed to innovation and invests heavily in research and development to improve the safety and efficacy of its products.